Literature DB >> 3591950

Renal autoregulation and vulnerability to hypertensive injury in remnant kidney.

A K Bidani, M M Schwartz, E J Lewis.   

Abstract

The remnant kidney model is characterized by moderate hypertension, proteinuria, and progressive glomerular scarring, which are ameliorated by a low-protein diet or antihypertensive drugs. The role of renal autoregulation, in determining vulnerability to hypertensive injury was investigated. After right nephrectomy and infarction of two-thirds of the left kidney, rats were fed an isocaloric normal (NP) or low-protein (LP) diet. After 3-4 wk blood pressure was not significantly different between NP and LP rats (171 +/- 8 vs. 155 +/- 6 mmHg), but urinary protein excretion was higher in NP rats (32.3 +/- 7.3 vs. 7.0 +/- 1.2 mg/24 h P less than 0.05). Measurement of renal plasma flow and glomerular filtration rate (GFR) after graded changes in renal perfusion pressure (100-160 mmHg) demonstrated poor autoregulation in NP but not in LP rats. Morphological evidence of severe injury in the form of fibrinoid necrosis and thrombosis of arterioles and glomeruli was largely confined to NP rats and became more severe after 6-8 wk. We conclude that remnant kidney rats fed NP diet autoregulate poorly, which may account for the malignant hypertensive injury to "unprotected" glomeruli, despite only moderate systemic hypertension, and contribute to the progressive nephron loss that is encountered.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3591950     DOI: 10.1152/ajprenal.1987.252.6.F1003

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  34 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

2.  Critical blood pressure threshold dependence of hypertensive injury and repair in a malignant nephrosclerosis model.

Authors:  Karen A Griffin; Aaron Polichnowski; Natalia Litbarg; Maria Picken; Manjeri A Venkatachalam; Anil K Bidani
Journal:  Hypertension       Date:  2014-06-23       Impact factor: 10.190

3.  Decreased renal haemodynamic response to inhibition of nitric oxide synthase in subtotally nephrectomized rats.

Authors:  J Wagner; A Wystrychowski; H Stauss; D Ganten; E Ritz
Journal:  Pflugers Arch       Date:  1995-06       Impact factor: 3.657

Review 4.  Recent advances in renal hemodynamics: insights from bench experiments and computer simulations.

Authors:  Anita T Layton
Journal:  Am J Physiol Renal Physiol       Date:  2015-02-25

5.  Knockout of Dual-Specificity Protein Phosphatase 5 Protects Against Hypertension-Induced Renal Injury.

Authors:  Chao Zhang; Xiaochen He; Sydney R Murphy; Huawei Zhang; Shaoxun Wang; Ying Ge; Wenjun Gao; Jan M Williams; Aron M Geurts; Richard J Roman; Fan Fan
Journal:  J Pharmacol Exp Ther       Date:  2019-05-22       Impact factor: 4.030

6.  Impaired autoregulation of glomerular capillary hydrostatic pressure in the rat remnant nephron.

Authors:  J C Pelayo; J Y Westcott
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

7.  Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy.

Authors:  Aaron J Polichnowski; Hector Licea-Vargas; Maria Picken; Jianrui Long; Rashmi Bisla; Geoffrey A Williamson; Anil K Bidani; Karen A Griffin
Journal:  Am J Physiol Renal Physiol       Date:  2015-06-24

Review 8.  Regional renal blood flow in normal and disease states.

Authors:  M C Regan; L S Young; J Geraghty; J M Fitzpatrick
Journal:  Urol Res       Date:  1995

Review 9.  Potential risks of calcium channel blockers in chronic kidney disease.

Authors:  Karen A Griffin; Anil K Bidani
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

10.  Effects of manidipine vs. amlodipine on intrarenal haemodynamics in patients with arterial hypertension.

Authors:  Christian Ott; Markus P Schneider; Ulrike Raff; Martin Ritt; Kristina Striepe; Marco Alberici; Roland E Schmieder
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.